A detailed history of Mather Group, Llc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 1,660 shares of MRVI stock, worth $7,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,660
Previous 1,660 -0.0%
Holding current value
$7,337
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

SELL
$6.87 - $11.34 $233 - $385
-34 Reduced 2.01%
1,660 $11,000
Q1 2024

Apr 08, 2024

BUY
$5.11 - $8.76 $8,656 - $14,839
1,694 New
1,694 $14,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $581M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.